Market Overview

UPDATE: Citigroup Initiates Maximus at Buy on Health Care Reform Opportunities

Share:
Related MMS
Stocks Hitting 52-Week Highs
Earnings Scheduled For November 13, 2014

Citigroup initiated coverage on Maximus (NYSE: MMS) with a Buy rating and a $75 price target.

Citigroup said, "Over the next three years, we think Maximus can more than double earnings. The company will continue to benefit from states moving fee for service Medicaid programs over to managed care. Moreover, Health Reform creates incremental growth opportunities from the Medicaid expansion and health exchanges. We think earnings can grow to $4.20 per share in 2015, and estimate the benefit of health exchanges and capital deployment could add another $0.70 per share."

Maximus closed at $63.09 on Monday.

Latest Ratings for MMS

DateFirmActionFromTo
May 2015JefferiesMaintainsBuy
Mar 2015Maxim GroupMaintainsBuy
Mar 2015Wells FargoInitiates Coverage onOutperform

View More Analyst Ratings for MMS
View the Latest Analyst Ratings

Posted-In: CitigroupAnalyst Color Initiation Intraday Update Analyst Ratings

 

Related Articles (MMS)

Get Benzinga's Newsletters